Today, CAR T cells are also investigated in solid tumors such as CRC, either targeting, among others, Carcinoembryonic Antigen (CEA) (NCT04348643, NCT02349724, NCT04513431) or tyrosine-kinase Met (c-Met) (NCT03638206). This evidence concerns the gene CEACAM5 and colorectal carcinoma.